Showing results (81-90 of 91) with videos related to
Sort By:
Pageof 10
Journal of Nanobiotechnology|January 30, 2021
Development of multivalent nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike proteinQizhong Lu, Zongliang Zhang, Hexian Li, et al.Journal of Translational Medicine|January 12, 2023
A drug screening to identify novel combinatorial strategies for boosting cancer immunotherapy efficacyZongliang Zhang, Guoqing Wang, Kunhong Zhong, et al.Molecular Therapy Oncolytics|April 30, 2020
B7-H3-Targeted CAR-T Cells Exhibit Potent Antitumor Effects on Hematologic and Solid TumorsZongliang Zhang, Caiying Jiang, Zhiyong Liu, et al.Cancer Letters|March 1, 2024
Improved antitumor effects elicited by an oncolytic HSV-1 expressing a novel B7H3nb/CD3 BsAbZongliang Zhang, Nian Yang, Huaqing Lu, et al.Medcomm|April 16, 2026
Combination of Vaccine With IL-12-Armed Oncolytic Virus SKV-012 Synergistically Potentiates Immune Responses in HPV-Associated MalignanciesNian Yang, Long Xu, Meijun Zheng, et al.Molecular Cancer Therapeutics|November 27, 2024
Development and Characterization of a Lysosome-Targeting SLC3A2/PD-L1 Bispecific Antibody-Drug Conjugate for Enhanced Antitumor Efficacy in Solid TumorsZeng Wang, Meijun Zheng, Mengyao Li, et al.Cell Reports. Medicine|October 9, 2025
A nanobody-based tri-specific NK cell engager targeting CD5 triggers antitumor immunityChen Yang, Ping Wang, Mingjun Yang, et al.Journal for Immunotherapy of Cancer|June 29, 2022
Genome-scale CRISPR-Cas9 screen reveals novel regulators of B7-H3 in tumor cellsShasha Zhao, Yuelong Wang, Nian Yang, et al.International Urology and Nephrology|September 24, 2008
Quantitative risk stratification and individual comprehensive therapy for invasive bladder cancers in ChinaHai Tao Niu, Haitao Niu, Shi Xiu Shao, et al.Theranostics|September 15, 2020
Combination therapy with B7H3-redirected bispecific antibody and Sorafenib elicits enhanced synergistic antitumor efficacyCheng Huang, Hongjian Li, Yunyu Feng, et al.Pageof 10